Substituted imidazotriazines

US7202243B2 · kind B2 · utility

Assignee

• BAYER HEALTHCARE LLC · DE

Inventors

• Ulrich Niewohner · Wermelskirchen, DE
• David Bruckner · Essen, DE
• Arno Friedl · Bensberg, DE
• Irene Gerlach · Cologne, DE
• Volker Hinz · Cologne, DE
• Jörg Keldenich · Wuppertal, DE
• Frank Mauler · Overath, DE
• Dagmar Karthaus · Solingen, DE
• Karl-Heinz Schlemmer · Wuppertal, DE
• Adrian Tersteegen · Wuppertal, DE
• Ozkan Yalkinoglu · Wuppertal, DE
• Ulrich Niewhner, deceased · Wermelskirchen, DE

Key dates

• Filing date: Jun 25, 2003
• Grant date: Apr 10, 2007
• Expiry date: Jun 25, 2023

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P25/28
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to new substituted imidazotriazines, processes for their preparation and their use for the production of medicaments for the treatment and/or prophylaxis of cancer and neurodegenerative disorders, in particular of Parkinson's disease and of schizophrenia.